Role of poly (ADP) ribose polymerase-1 inhibition by nicotinamide as a possible additive treatment to modulate host immune response and prevention of cytokine storm in COVID-19
Volume 72 | Issue 1 | January-April 2020
We value your privacy
We use necessary cookies to run this website. With your consent, we may also use analytics, preference, functional, and marketing cookies.
